|
Report No. : |
321891 |
|
Report Date : |
15.05.2015 |
IDENTIFICATION DETAILS
|
Name : |
AL DOMA PHARMA CO LTD |
|
|
|
|
Registered Office : |
Almona Building No. 3, 2nd Floor, Khartoum North, Alsababi,
Khartoum |
|
|
|
|
Country : |
Sudan |
|
|
|
|
Date of Incorporation : |
16.01.2005 |
|
|
|
|
Legal Form : |
Limited Liability Company |
|
|
|
|
Line of Business : |
Engaged in the import and distribution of pharmaceuticals, drugs and
medicines. |
|
|
|
|
No. of Employees : |
6 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – December 31, 2014
|
Country Name |
Previous Rating (30.09.2014) |
Current Rating (31.12.2014) |
|
Sudan |
C2 |
C2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
SUDAN - ECONOMIC OVERVIEW
Sudan is an extremely poor country that has experienced
protracted social conflict, civil war, and, in July 2011, the loss of three-quarters
of its oil production due to the secession of South Sudan. The oil sector had
driven much of Sudan's GDP growth since 1999. For nearly a decade, the economy
boomed on the back of rising oil production, high oil prices, and significant
inflows of foreign direct investment. Since the economic shock of South Sudan's
secession, Sudan has struggled to stabilize its economy and make up for the
loss of foreign exchange earnings. The interruption of oil production in South
Sudan in 2012 for over a year and the consequent loss of oil transit fees
further exacerbated the fragile state of Sudan’s economy. Sudan is also subject
to comprehensive US sanctions. Sudan is attempting to develop non-oil sources
of revenues, such as gold mining, while carrying out an austerity program to
reduce expenditures. The world’s largest exporter of gum Arabic, Sudan produces
75-80% of the world’s total output. Agriculture continues to employ 80% of the
work force. Sudan introduced a new currency, still called the Sudanese pound,
following South Sudan's secession, but the value of the currency has fallen
since its introduction. Khartoum formally devalued the currency in June 2012,
when it passed austerity measures that included gradually repealing fuel
subsidies. Sudan also faces rising inflation, which reached 47% on an annual
basis in November 2012, but subsided to 37% in 2014. Ongoing conflicts in
Southern Kordofan, Darfur, and the Blue Nile states, lack of basic
infrastructure in large areas, and reliance by much of the population on
subsistence agriculture keep close to half of the population at or below the
poverty line.
|
Source
: CIA |
Company Name :
AL DOMA PHARMA CO LTD
Country of Origin :
Sudan
Legal Form :
Limited Liability Company
Registration Date :
16th January 2005
Issued Capital :
SD 500,000
Paid up Capital :
SD 500,000
Total Workforce : 6
Activities :
Distributors of pharmaceuticals, drugs and medicines
Financial Condition :
Undetermined
Payments :
Nothing detrimental uncovered
AL DOMA PHARMA CO LTD
Registered &
Physical Address
Building :
Almona Building No. 3, 2nd Floor
Area : Khartoum
North, Alsababi
Town : Khartoum
Country : Sudan
Mobile : (249-912) 286327
/ (249-123) 474444
Email : aldomapharma@gmail.com
/ info@aldomapharmaco.com
Premises
Subject operates from a small suite of offices that are rented and located
in the Central Business Area of Khartoum.
Name Position
Dr Mohamed Noor Jobarah Managing
Director
Date of Establishment : 16th
January 2005
Legal Form : Limited Liability
Company
Issued Capital : SD 500,000
Paid up Capital : SD 500,000
Name of
Shareholder (s) Percentage
Dr Mohamed Noor Jobarah 100%
Activities: Engaged in the import and distribution of pharmaceuticals, drugs and
medicines.
Import Countries: Europe and Pakistan
Agencies Held:
Jetz Pharma Pakistan
Subject has a workforce of 6 employees.
Companies registered in Sudan are not legally required to make their
accounts public and no financial information was released by the company or
submitted by outside sources.
Tadamon Islamic Bank
Baladiya Street
Khartoum
Tel: (249-183) 771505
Al Shamal Islamic Bank
El Sayed Abdurrahman Street
Khartoum
Tel: (249-183) 779078
No complaints regarding subject’s payments have been reported.
During the course of this investigation nothing detrimental was
uncovered regarding subject’s operating history or the manner in which payments
are fulfilled. As such the company is considered to be a fair trade risk.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.63.84 |
|
|
1 |
Rs.100.65 |
|
Euro |
1 |
Rs.72.88 |
INFORMATION DETAILS
|
Analysis Done by
: |
DIV |
|
|
|
|
Report Prepared
by : |
TPT |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
|
-- |
NB |
New Business |
-- |
|
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major
sections of this report. The assessed factors and their relative weights (as
indicated through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.